S03 E11: How to enhance value and access across pharma

This week, the GOLD team shares a conversation with Christoph Glaetzer, Chief Global Value and Access Officer, Johnson & Johnson. He discusses his lengthy career within value and access and his drive to enter the industry, his proudest achievements while working at J&J and the importance of having a good leader to learn from. And in news you might have missed, the team showcases some recent investment in the psychedelics market, a first-in-10-years paediatric vaccine and a new study investigating the prevalence of undiagnosed CKD. If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: Behind the headlines of the inflation reduction act https://www.emg-gold.com/post/behind-the-headlines-of-the-inflation-reduction-act Pharma in South Africa, access, pricing and reimbursement https://www.emg-gold.com/post/podcast-pharma-in-south-africa-access-pricing-and-reimbursement Margo Warren on global access to medicine https://www.emg-gold.com/post/podcast-margo-warren-on-global-access-to-medicine

There are no comments yet.

Please log in to write the first comment.